# Marti Technologies, Inc.: financial statements, quarterly

MRT · NYSE · CIK 1852767 · [Other](/sectors/other.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mrt.md) · [Financials](/companies/mrt/financials.md) · [Filings](/companies/mrt/filings.md) · [Insiders](/companies/mrt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mrt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2021 (2021-06-30) | Q3 FY2021 (2021-09-30) | Q1 FY2022 (2022-03-31) | Q1 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q4 FY2022 (2022-12-31) | Q1 FY2023 (2023-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Net income | $m | [(0.0)](/filings/0001410578-22-003193.md) | [(0.1)](/filings/0001410578-22-003193.md) | [(0.8)](/filings/0001410578-23-001271.md) | [(0.3)](/filings/0001410578-22-003193.md) | [(0.6) d](/filings/0001410578-22-003193.md) | [(12.5) d](/filings/0001213900-25-036882.md) | [1.2](/filings/0001410578-23-001271.md) |
| Diluted EPS | $ per share | [0.00](/filings/0001104659-21-108617.md) | not reported | not reported | not reported | not reported | not reported | not reported |

- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareBasicAndDiluted

## Balance sheet

| Line item | Unit | period not labelled (2021-03-31) | Q2 FY2021 (2021-06-30) | Q3 FY2021 (2021-09-30) | FY2021 (2021-12-31) | Q1 FY2022 (2022-03-31) | Q1 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | FY2022 (2022-12-31) | Q1 FY2023 (2023-03-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [0.0](/filings/0001104659-21-108617.md) | [0.6](/filings/0001410578-21-000289.md) | [0.6](/filings/0001410578-23-000560.md) | [0.6](/filings/0001410578-22-001808.md) | [0.5](/filings/0001410578-22-002289.md) | [0.3](/filings/0001410578-22-003193.md) | [10.5](/filings/0001213900-24-033158.md) | [0.1](/filings/0001410578-23-001271.md) | [19.4](/filings/0001213900-25-036882.md) | [5.1](/filings/0001213900-26-042974.md) | [7.8](/filings/0001213900-26-042974.md) |
| Current assets | $m | not reported | not reported | [0.8](/filings/0001410578-21-000289.md) | [0.8](/filings/0001410578-23-000560.md) | [0.7](/filings/0001410578-22-001808.md) | [0.6](/filings/0001410578-22-002289.md) | [0.4](/filings/0001410578-22-003193.md) | [20.5](/filings/0001213900-24-033158.md) | [0.2](/filings/0001410578-23-001271.md) | [25.7](/filings/0001213900-25-036882.md) | [11.4](/filings/0001213900-26-042974.md) | [13.9](/filings/0001213900-26-042974.md) |
| Total assets | $m | not reported | [0.4](/filings/0001104659-21-108617.md) | [148](/filings/0001410578-21-000289.md) | [147](/filings/0001410578-23-000560.md) | [147](/filings/0001410578-22-001808.md) | [147](/filings/0001410578-22-002289.md) | [148](/filings/0001410578-22-003193.md) | [40.9](/filings/0001213900-24-033158.md) | [151](/filings/0001410578-23-001271.md) | [40.2](/filings/0001213900-25-036882.md) | [20.4](/filings/0001213900-26-042974.md) | [29.8](/filings/0001213900-26-042974.md) |
| Current liabilities | $m | not reported | [0.4](/filings/0001104659-21-108617.md) | [0.0](/filings/0001410578-21-000289.md) | [0.7](/filings/0001410578-23-000560.md) | [1.5](/filings/0001410578-22-001808.md) | [1.9](/filings/0001410578-22-002289.md) | [2.7](/filings/0001410578-22-003193.md) | [15.9](/filings/0001213900-24-033158.md) | [3.4](/filings/0001410578-23-001271.md) | [17.5](/filings/0001213900-25-036882.md) | [11.3](/filings/0001213900-26-042974.md) | [14.4](/filings/0001213900-26-042974.md) |
| Total liabilities | $m | not reported | not reported | [5.1](/filings/0001410578-21-000289.md) | [5.7](/filings/0001410578-23-000560.md) | [6.5](/filings/0001410578-22-001808.md) | [6.9](/filings/0001410578-22-002289.md) | [7.7](/filings/0001410578-22-003193.md) | [33.3](/filings/0001213900-24-033158.md) | [8.4](/filings/0001410578-23-001271.md) | [72.9](/filings/0001213900-25-036882.md) | [81.8](/filings/0001213900-26-042974.md) | [96.9](/filings/0001213900-26-042974.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [23.7](/filings/0001213900-24-033158.md) | not reported | [54.8](/filings/0001213900-25-036882.md) | [70.1](/filings/0001213900-26-042974.md) | [82.1](/filings/0001213900-26-042974.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [7.3](/filings/0001213900-24-033158.md) | not reported | [10.4](/filings/0001213900-25-036882.md) | [4.6](/filings/0001213900-26-042974.md) | [3.7](/filings/0001213900-26-042974.md) |
| Shareholders' equity | $m | [0.0](/filings/0001410578-22-003193.md) | [0.0](/filings/0001410578-22-003193.md) | [(1.3)](/filings/0001410578-22-003193.md) | [20.5](/filings/0001213900-25-036882.md) | [(2.9)](/filings/0001410578-23-001271.md) | [(3.4)](/filings/0001410578-22-003193.md) | [(4.4)](/filings/0001410578-22-003193.md) | [7.6](/filings/0001213900-26-042974.md) | [(5.3)](/filings/0001410578-23-001271.md) | [(32.7)](/filings/0001213900-26-042974.md) | [(61.4)](/filings/0001213900-26-042974.md) | [(67.1)](/filings/0001213900-26-042974.md) |

- Cash and equivalents: us-gaap:Cash, us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt, us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:DebtCurrent, us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2022 (2022-03-31) | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q4 FY2022 (2022-12-31) | Q1 FY2023 (2023-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(9.2)](/filings/0001410578-23-001271.md) | [(105) d](/filings/0001410578-22-002289.md) | [(185) d](/filings/0001410578-22-003193.md) | [(5,166) d](/filings/0001213900-25-036882.md) | [(109)](/filings/0001410578-23-001271.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

Shares outstanding: 86,042,726 at 2025-12-31, from the cover of the [20-F filed 2026-04-13](/filings/0001213900-26-042974.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.